Midgard Science
CO

Champions Oncology

Hackensack, NJ, United States championsoncology.com

From their website, Nov 2026

Work here? Claim this listing

About

Champions Oncology is a preclinical oncology CRO providing patient-derived models, ex vivo and in vivo studies, and multi-omic data services for drug developers and researchers. It serves oncology programs across solid tumors, hematologic malignancies, CDX and PDX models, with operations in Hackensack, New Jersey; Rockville, Maryland; and Rehovot, Israel. The company also supports global studies through scientific consultation, model selection, and analytical readouts.

Services

  • Solid Tumor PDX Models

    Provides patient-derived xenograft models for solid tumor oncology research with clinical annotation and multi-omic characterization.

  • Blood Cancer Models

    Offers hematological tumor and leukemia xenograft models including AML, ALL, CLL, lymphoma, and multiple myeloma for preclinical testing.

  • Pretreated PDX Models

    Provides PDX models from pretreated patients to study resistance mechanisms, next-line therapies, and clinical translation.

  • CDX Models

    Offers cell line-derived xenograft models for proof-of-concept, target validation, resistance studies, and biomarker work.

  • PDX Model Bank

    Maintains a searchable bank of patient-derived tumor models for selecting models by tumor indication, modality, or molecular profile.

  • CDX Model Bank

    Provides a filtered bank of CDX models for selection by tumor indication, genetic profile, and gene expression.

  • TumorGraft3D Ex Vivo Platform

    Supports selected ex vivo studies using low-passage, PDX-derived 3D tumor models for cohort comparison and translational questions.

    Assays & in vitro testing

  • Hematological VitroScreen

    Runs ex vivo hematologic assays to test therapeutics in blood cancer models.

    Assays & in vitro testing

  • Ex Vivo Solid Tumor Screening

    Uses PDX-derived ex vivo solid tumor models for therapeutic screening and comparative studies.

    Assays & in vitro testing

  • In Vivo Preclinical Mouse Models

    Conducts preclinical in vivo studies in clinically annotated mouse models for oncology programs.

  • In Vivo Screening (Mouse Clinical Trials)

    Performs in vivo screening studies in mouse models for oncology drug evaluation.

  • Matched Multi-Omic Dataset

    Provides matched genomic, proteomic, clinical, and response data from patient-derived tumor models as a licensed dataset or analysis package.

    Genomics & sequencing

  • Lumin Data Platform

    Offers browsable molecular, treatment-history, and prior-response records for PDX and CDX model selection.

    Genomics & sequencing

  • Cell Surface Proteomics Dataset

    Provides matched whole-cell and cell-surface proteomics from patient-derived tumor models for target discovery and validation.

    Genomics & sequencing

  • KRAS-Mutant Atlas

    Provides a reference atlas comparing KRAS-mutant models under daraxonrasib and optional comparator arms.

    Assays & in vitro testing

  • Radiopharmaceutical Services

    Supports radiochemistry and in-house SPECT/CT imaging for radiopharma programs.

  • Analytical Assays

    Offers analytical readouts including flow cytometry, histology/IHC, ELISA/Luminex, next-generation sequencing, proteomics, western blot, DNA damage assays, CFU assay, imaging, cell viability/proliferation, and qPCR.

    Assays & in vitro testing

  • Co-Culture Assays

    Runs co-culture assays as part of ex vivo and analytical oncology workflows.

    Assays & in vitro testing

  • Ex Vivo Hematological Cancer Screen

    Runs ex vivo screening for hematological cancers to evaluate therapeutic responses outside the animal model.

    Assays & in vitro testing

  • Flow Cytometry

    Provides flow cytometry-based analytical services for oncology studies.

    Assays & in vitro testing

  • Histology / IHC

    Offers histology and immunohistochemistry analysis for tumor characterization and study readouts.

    Assays & in vitro testing

  • ELISA / Luminex

    Performs ELISA and Luminex assays for biomarker and protein measurement.

    Assays & in vitro testing

  • Next Generation Sequencing

    Provides NGS-based molecular analysis for characterizing models and study samples.

    Genomics & sequencing

  • 4D Proteomics

    Offers proteomics analysis to support molecular characterization and biomarker discovery.

    Assays & in vitro testing

  • Western Blot

    Performs Western blot analysis for protein detection and validation.

    Assays & in vitro testing

  • DNA Damage Assays

    Runs assays to measure DNA damage responses in oncology models.

    Assays & in vitro testing

  • Colony Forming Unit (CFU) Assay

    Provides CFU assays for hematological and functional cellular readouts.

    Assays & in vitro testing

  • Imaging

    Offers imaging services for preclinical oncology studies, including longitudinal SPECT/CT imaging for radiopharmaceuticals.

    Assays & in vitro testing

  • Cell Viability & Proliferation

    Measures cell viability and proliferation as study readouts in oncology models.

    Assays & in vitro testing

  • Quantitative PCR

    Provides qPCR for nucleic acid-based measurement and analysis.

    Assays & in vitro testing

Turnaround
Within 24 hours · Within one business day
What to send
Leukapheresis · Peripheral blood · Bone marrow aspirates · Biopsies of patients with advanced-stage disease

Capabilities

Assays and studies
In vivo · Rodent models · Flow cytometry · NGS · ADCs · ELISA · Antibodies · Histology · IHC · Luminex · Next generation sequencing · 4D proteomics
11 moreWestern blot · DNA damage assays · Colony forming unit (CFU) assay · Imaging · Cell viability · Proliferation · Quantitative PCR · Co-culture assays · Proteomics · Phospho-proteomics · CFU assay
Scale and capacity
Over 1,500 patient-derived models · Over 1,400 patient-derived models · 700+ pretreated PDX models · 600+ cell-surface profiled models · 300+ TumorGraft3D models · 1,615 RNA-Seq models · 1,599 whole-exome models · 1,006 whole-cell protein models · 607 surface proteomics models · Over 1,500 highly characterized PDX models · 700+ pretreated models · Over 100 cell-line derived xenograft mouse models
1 more35,000 sq. ft. Rockville, MD research facility
Therapeutic areas
Oncology · Solid tumors · Hematologic malignancies · Bladder cancer · Prostate cancer · Kidney cancer · Melanoma · Skin cancer · Breast cancer · Colorectal cancer · Leukemia · Lymphoma
1 moreMultiple myeloma

Instruments and platforms

  • SPECT/CT
  • LC-MS
  • IVIS

Modalities and species

Modalities
Small molecule · Antibody · Bispecific · ADC · Cell therapy
Species and models
Human · Mouse · Patient-derived xenograft (PDX) · Cell line-derived xenograft (CDX) · Acute myeloid leukemia (AML) · Acute lymphoblastic leukemia (ALL) · Chronic lymphoblastic leukemia (CLL) · Diffuse large B-cell lymphoma (DLBCL) · Mantle cell lymphoma · Multiple myeloma · NSCLC · Colorectal cancer
8 morePancreatic cancer · Patient-derived xenografts (PDX) · Cell line-derived xenografts (CDX) · Syngeneic mouse models · Humanized mouse models · Solid tumor models · Blood cancer models · Hematological cancer models

Industries served

  • Biotech
  • Pharma
  • Oncology

Company

Type
CRO
Founded
2007
Quality
GCLP (clinical flow cytometry services)

Locations

Address
1330 Piccard Drive, Suite 025 & Suite 104 Rockville, MD 20850, USA
Sites
Hackensack, USA · Rockville, USA · Rehovot, Israel
Serves
global, U.S., globally, U.S.-based

Contacts

Similar labs

Work here? Claim this listing